Evaluation of medication adherence over a decade following kidney transplantation: integration of biological and self-reported data
Yaprak Sarıgöl Ordin, Serap Arıcan, Büşra Selma Saha, Hale Turhan Damar · 2026
Read Evaluation of medication adherence over a decade following kidney transplantation: integration of biological and self-reported data by Yaprak Sarıgöl Ordin, Serap Arıcan, Büşra Selma Saha, Hale Turhan Damar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471471.txt.
Description
Ordin and co-authors tracked whether kidney transplant patients keep taking their anti-rejection medicines over a decade, checking blood drug levels against what patients say. Their 2026 study followed 103 recipients at 12 time points, averaging 11.77 years since transplantation, using tacrolimus and cyclosporine levels as the biological yardstick.
Biological testing classed 43.3% of patients as poorly adherent, while self-reports claimed adherence of 82.52% across the same group, and the two measures showed no significant correlation. Patients with low biological adherence had higher blood urea nitrogen at six months and nine years after transplant. Scores were also significantly lower in patients who had suffered graft rejection, tying missed doses to real organ risk.
Catalog record
| CREATOR | Yaprak Sarıgöl Ordin, Serap Arıcan, Büşra Selma Saha, Hale Turhan Damar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |